Effect of Anastrozole on Estrogen Levels in Post-Menopausal Women with Breast Cancer
Author Information
Author(s): J Geisler, N King, M Dowsett, L Ottestad, S Lundgren, P Walton, PO Kormeset, PE L0nning
Primary Institution: Haukeland University Hospital
Hypothesis
Does anastrozole effectively inhibit aromatization and suppress plasma estrogen levels in post-menopausal women with breast cancer?
Conclusion
Anastrozole is highly effective in inhibiting aromatization and suppressing plasma estrogen levels in post-menopausal women with breast cancer.
Supporting Evidence
- Anastrozole reduced aromatization from 2.25% to 0.074% and 0.043% for 1 mg and 10 mg doses respectively.
- Plasma levels of oestrone, oestradiol, and oestrone sulphate were suppressed by over 86.5%, 83.5%, and 93.5% respectively.
- All patients experienced a suppression of in vivo aromatization by over 93.7%.
Takeaway
Anastrozole helps lower estrogen levels in women with breast cancer, making it a good treatment option.
Methodology
Twelve post-menopausal women were randomized to receive either 1 mg or 10 mg of anastrozole daily for 28 days in a double-blinded crossover design.
Limitations
The study had a small sample size and included protocol deviators.
Participant Demographics
Mean age of participants was 65 years, and mean weight was 67 kg.
Statistical Information
P-Value
<0.005
Confidence Interval
95% confidence interval 1.73% - 2.92%
Statistical Significance
p<0.005
Want to read the original?
Access the complete publication on the publisher's website